drugset / Trial / NCT03263780

High Resolution PET-MRI Before Prostate Cancer HIFU

NCT03263780

NaSingle-groupOpen-labelOther

Summary

This prospective trial aims to determine if enhanced prostate imaging using two novel imaging technologies (high resolution DWI and 18F-fluciclovine PET-MRI) will detect prostate cancers not seen on standard multiparametric prostate MRI in patients considered candidates for focal HIFU.

Timeline

Start
2017-12-07
Primary completion
2020-01-08
Completion
2020-01-08

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-fluciclovine Diagnostic / imaging agent 370 mbq

Indications